Delivery Order SPE2DB24D8002-SPE2DB24FJMSS

Award Date 8/7/24
Potential Completion Date 8/8/24
Potential Value $10K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $9,135.66 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of JARDIANCE 25 MG TABLET 30S, a prescription medication, to support the DLA Troop Support Medical's medical supply chain operations. This delivery order is part of Dakota Drug's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA, which allows the company to provide a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $16,232.36 firm fixed-price contract is for the delivery of JARDIANCE 10 MG TABLET 90S, a prescription medication. The contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, valued at $999,999,999.00. This IDC allows Dakota Drug, Inc. to provide...
This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $14,001.99, is for the delivery of the pharmaceutical product JARDIANCE 25 MG TABLET 90S. The contract has a period of performance through November 14, 2024 and is not a set-aside award. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, valued...
This is a delivery order contract awarded to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) Troop Support Medical. The $22,523.22 firm fixed-price contract is for the supply of JARDIANCE 10 MG TABLET 90S, a pharmaceutical product used to treat diabetes. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to provide a comprehensive range of medical products...
This award is a Delivery Order contract valued at $3,052.83, issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of JARDIANCE 25 MG TABLET 30S, a prescription medication. This order is part of Dakota Drug's single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to provide a comprehensive range of pharmaceutical products, medical supplies, and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $27,657.68 firm fixed-price contract is for the delivery of Jardiance 10 mg tablets over a performance period ending on November 20, 2024. The contract was not set aside for any specific business category. This delivery order is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract, valued at $7,041.13, is for the delivery of the prescription medication Jardiance 25 mg tablets. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, valued at $999,999,999.00, which...
This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of Jardiance 25 mg tablets over a period ending on November 5, 2024, with a ceiling value of $2,216.62. The contract is not set aside and is part of the DLA Troop Support Medical's ECAT Generation V Program, a larger indefinite delivery contract (IDC) with Dakota Drug, Inc. valued at $999,999,999.00. This IDC...
This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, to provide 90 tablets of the prescription medication Jardiance 10 mg. The contract has a ceiling value of $4,835.60 and a performance period that runs through October 17, 2024. The award is not associated with a set-aside program. Dakota Drug, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued at...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a small disadvantaged business. The contract is for the supply of Jardiance 25 mg tablets, a medication used to treat diabetes. The total ceiling value of the contract is $3,984.67, with an ultimate completion date of August 20, 2024. This contract is part of a larger Indefinite Delivery Contract (IDC) between Dakota Drug, Inc. and the DLA, valued at $999,999,999.00, which...
  • SPE2DB24D8002
    Indefinite Delivery Contract
  • SPE2DB24D8002-SPE2DB24FJMSS
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract, valued at $10,076.98, is for the delivery of JARDIANCE 25 MG TABLET 90S, a prescription medication.

The contract is part of a larger Indefinite Delivery Contract (IDC) between Dakota Drug, Inc. and the DLA Troop Support Medical's ECAT Generation V Program, which has a ceiling value of $999,999,999.00. This single-award IDC allows Dakota Drug, Inc. to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations through December 31, 2025. The delivery order does not have a set-aside designation.

Generated 11/6/24, 9:22 AM